Risk stratification in the patient with unstable angina or non ST elevation MI: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +))
No edit summary
Line 1: Line 1:
__NOTOC__
{{SI}}
{{SI}}
{{CMG}}
{{CMG}}


==Definition==
==Definition==
Line 21: Line 19:
*TACTICS-TIMI 18: In patients with UA/NSTEMI who was treated with tirofiban, the use of early invasive strategy reduce the rate of the primary end point (death, non-fatal MI, and rehospitalization for ACS at 6 months) from 19.4% to 15.9%.
*TACTICS-TIMI 18: In patients with UA/NSTEMI who was treated with tirofiban, the use of early invasive strategy reduce the rate of the primary end point (death, non-fatal MI, and rehospitalization for ACS at 6 months) from 19.4% to 15.9%.


{{Electrocardiography}}
==References==
{{Circulatory system pathology}}
{{reflist|2}}
 
[[Category:Electrophysiology]]
[[Category:Electrophysiology]]
[[Category:Cardiology]]
[[Category:Cardiology]]
[[Category:Up-To-Date]]
[[Category:Up-To-Date cardiology]]


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Revision as of 16:54, 10 January 2013

WikiDoc Resources for Risk stratification in the patient with unstable angina or non ST elevation MI

Articles

Most recent articles on Risk stratification in the patient with unstable angina or non ST elevation MI

Most cited articles on Risk stratification in the patient with unstable angina or non ST elevation MI

Review articles on Risk stratification in the patient with unstable angina or non ST elevation MI

Articles on Risk stratification in the patient with unstable angina or non ST elevation MI in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Risk stratification in the patient with unstable angina or non ST elevation MI

Images of Risk stratification in the patient with unstable angina or non ST elevation MI

Photos of Risk stratification in the patient with unstable angina or non ST elevation MI

Podcasts & MP3s on Risk stratification in the patient with unstable angina or non ST elevation MI

Videos on Risk stratification in the patient with unstable angina or non ST elevation MI

Evidence Based Medicine

Cochrane Collaboration on Risk stratification in the patient with unstable angina or non ST elevation MI

Bandolier on Risk stratification in the patient with unstable angina or non ST elevation MI

TRIP on Risk stratification in the patient with unstable angina or non ST elevation MI

Clinical Trials

Ongoing Trials on Risk stratification in the patient with unstable angina or non ST elevation MI at Clinical Trials.gov

Trial results on Risk stratification in the patient with unstable angina or non ST elevation MI

Clinical Trials on Risk stratification in the patient with unstable angina or non ST elevation MI at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Risk stratification in the patient with unstable angina or non ST elevation MI

NICE Guidance on Risk stratification in the patient with unstable angina or non ST elevation MI

NHS PRODIGY Guidance

FDA on Risk stratification in the patient with unstable angina or non ST elevation MI

CDC on Risk stratification in the patient with unstable angina or non ST elevation MI

Books

Books on Risk stratification in the patient with unstable angina or non ST elevation MI

News

Risk stratification in the patient with unstable angina or non ST elevation MI in the news

Be alerted to news on Risk stratification in the patient with unstable angina or non ST elevation MI

News trends on Risk stratification in the patient with unstable angina or non ST elevation MI

Commentary

Blogs on Risk stratification in the patient with unstable angina or non ST elevation MI

Definitions

Definitions of Risk stratification in the patient with unstable angina or non ST elevation MI

Patient Resources / Community

Patient resources on Risk stratification in the patient with unstable angina or non ST elevation MI

Discussion groups on Risk stratification in the patient with unstable angina or non ST elevation MI

Patient Handouts on Risk stratification in the patient with unstable angina or non ST elevation MI

Directions to Hospitals Treating Risk stratification in the patient with unstable angina or non ST elevation MI

Risk calculators and risk factors for Risk stratification in the patient with unstable angina or non ST elevation MI

Healthcare Provider Resources

Symptoms of Risk stratification in the patient with unstable angina or non ST elevation MI

Causes & Risk Factors for Risk stratification in the patient with unstable angina or non ST elevation MI

Diagnostic studies for Risk stratification in the patient with unstable angina or non ST elevation MI

Treatment of Risk stratification in the patient with unstable angina or non ST elevation MI

Continuing Medical Education (CME)

CME Programs on Risk stratification in the patient with unstable angina or non ST elevation MI

International

Risk stratification in the patient with unstable angina or non ST elevation MI en Espanol

Risk stratification in the patient with unstable angina or non ST elevation MI en Francais

Business

Risk stratification in the patient with unstable angina or non ST elevation MI in the Marketplace

Patents on Risk stratification in the patient with unstable angina or non ST elevation MI

Experimental / Informatics

List of terms related to Risk stratification in the patient with unstable angina or non ST elevation MI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Definition

  • Unstable angina: acute ischemic symptoms, with or without EKG changes (ST depression/transient ST elevation/new T wave inversion), and absence of troponin or CK-MB elevation.
  • Non ST elevation MI: acute ischemic symptoms, with or without EKG changes (ST depression/transient ST elevation/new T wave inversion), and presence of troponin or CK-MB elevation.

Risk stratification in patient with UA/NSTEMI

  • The Thrombolysis in Myocardial Infarction (TIMI) risk score for UA/NSTEMI:
    • The TIMI risk score for STEMI was created from simple arithmetic sum of independent predictors of mortality weighted according to the adjusted odds ratios from logistic regression analysis.
    • The patient pool (n=1957) came from the TIMI 11B trial.
    • The TIMI risk score was subsequently validated using the unfractionated heparin group from the ESSENCE trial and the enoxaparin groups from both the TIMI 11B and the ESSENCE trials.
    • TIMI risk score of 0-2 = low risk, TIMI risk score of 3-4 = moderate risk, TIMI risk score of 5-7 = high risk.
  • ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention:
    • The guideline defined high risk as elevated cardiac enzymes, ST segment depression, recurrent angina, hemodynamic instability, sustained VT/VF, history of DM, prior PCI in the past 6 months or CABG.

Early invasive strategy vs non-invasive strategy

  • TACTICS-TIMI 18: In patients with UA/NSTEMI who was treated with tirofiban, the use of early invasive strategy reduce the rate of the primary end point (death, non-fatal MI, and rehospitalization for ACS at 6 months) from 19.4% to 15.9%.

References


Template:WikiDoc Sources